Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

Affimed N.V.. (3/20/18). "Press Release: Affimed Reports Financial Results for Fourth Quarter and Year End 2017". Heidelberg.

Organisations Organisation Affimed N.V. (Nasdaq: AFMD)
  Group Affimed (Group)
  Organisation 2 Nasdaq Global Market
  Group Nasdaq OMX (Group)
Products Product AFM13 (Affimed)
  Product 2 AFM24 (EGFRwt/CD16A TandAb, Affimed)
Persons Person Alland, Leila (Affimed 201803– CMO before Tarveda Therapeutics + AstraZeneca + BMS + Novartis)
  Person 2 Fischer, Wolfgang (Affimed 201709– COO before Sandoz Biopharmaceuticals + Novartis)
     


   
Record changed: 2018-03-31

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

More documents for Affimed (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top